NM_033380.3(COL4A5):c.2692A>G (p.Met898Val) AND Autosomal dominant Alport syndrome
- Germline classification:
- no classifications from unflagged records (1 submission)
- Last evaluated:
- Dec 13, 2023
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001849276.3
Allele description [Variation Report for NM_033380.3(COL4A5):c.2692A>G (p.Met898Val)]
NM_033380.3(COL4A5):c.2692A>G (p.Met898Val)
Condition(s)
- Name:
- Autosomal dominant Alport syndrome (ATS3A)
- Synonyms:
- Alport syndrome dominant type; Renal failure and sensorineural hearing loss; Alport syndrome 3, autosomal dominant; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0007086; MedGen: C5882663; Orphanet: 63; Orphanet: 88918; OMIM: 104200
Assertion and evidence details
Flagged submissions
Submission Accession | Submitter | Review Status (Assertion method) | Clinical Significance (Last evaluated) | Origin | Method | Citations |
---|---|---|---|---|---|---|
SCV002106605 | Yale Center for Mendelian Genomics, Yale University - Yale Center for Mendelian Genomics | flagged submission Reason: Outlier claim with insufficient supporting evidence Notes: None | Pathogenic (Feb 14, 2019) | germline | literature only |
Last Updated: Dec 22, 2024